Linnet Biopharmaceuticals Receives Drug Patent for Removing Caffeine

Company creates caffeine removing drug derived from the unique fruit, Evodia.

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friendRepost This

Redding, CA (PRWEB) May 21, 2014

Linnet Biopharmaceuticals has received a patent http://bit.ly/Drug-Patent for its treatment mechanism for countering the effects of caffeine, after dedicating years of research and development to improving the quality of sleep by removing caffeine from the body. Millions of Americans suffer from some degree of insomnia due to caffeine consumption, although many are unwilling to sacrifice the positive aspects of use that include increased energy and focus.

The rigorous patent approval process comes after exhaustive experiments and drug discovery research. "We have created a new drug that has the aim of removing caffeine from the body quickly, as opposed to between 10 and 15 hours that it would naturally take," said Tim Linnet, CEO of Linnet Biopharmaceuticals.

"We have undertaken extensive research and testing, and have received a patent and are also in compliance with the most recent policy updates of the US Food and Drug Administration. Linnet's patent, “Rutaecarpine derivatives for activating CYP1A2 in a subject." Has potential prescription uses such as treatment for insomnia, caffeine overdose, theophylline overdose, cardiovascular disorders, and caffeine reduction prior to Lexiscan induced stress test.

Linnet Biopharmaceuticals is now actively seeking partnerships or a license/sale of the IP to carry it through the next phase of FDA approval.

“The whole idea behind the creation of the product was to help improve the quality of life for individuals everywhere,” said Linnet. “People shouldn’t have to sacrifice sleep for productivity or the other way around."

To financially support its prescription drug research, Linnet also has developed a dietary supplement line RutaSleep http://rutasleep.com/products/rutasleep. The product promotes natural sleep through the ingredients Melatonin and Rutaecarpine (Normally found in the Evodia fruit). RutaSleep is made in the USA with good manufacturing practices (GMPs) outlined by the Food and Drug Administration's most recent amendments. By some estimates, only 10 percent of dietary supplements follow these rigorous guidelines. By holding its products to the highest quality of government standards, Linnet is able to offer a quality, reliable products.

About Linnet Biopharmaceuticals:

The research and development team behind Linnet's products is made up of 30 year pharmacist veterans in both retail and hospital, double doctorate professors with years of experience in their products specific scientific applications, and nutritionists that know what it means to support a naturally acting and safe product.


Contact